Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Entrepreneur Type: Vensana

Cleerly

CVRx

SpyGlass Pharma

Alleviant Medical

GPB

Vesper Medical

Relievant

PGDx

Intact

17

Novel FDA PMA & de novo 510k approvals

40

U.S. Commercial Product Launches

34

Level I Clinical Trials

25

Strategic Financings

26

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together?

Get in Touch

Our Latest

See All News
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
Resources
News LP Access
Contact
info@vensanacap.com 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2021 Vensana Capital Management, LLC | Privacy | Terms & Conditions